Panel suggests remdesivir as preferred antiviral for pediatric COVID-19 patients

In new guidance, a panel of pediatric infectious diseases physicians and pharmacists suggested that supportive care alone is sufficient to treat most children with COVID-19. Among children who develop severe or critical cases — a rare occurrence — the […]

Click here to view original web page at Panel suggests remdesivir as preferred antiviral for pediatric COVID-19 patients